The Longitudinal Relationship of Hydroxyurea Adherence Behavior to Health-related Quality of Life, Barriers to Adherence and Habit Formation in Patients With Sickle Cell Disease.

Study point of contact

Kathryn King, BS
(312) 227-4825
[email protected]
Sherif M. Badawy, MD, MS
(312) 227-4836
[email protected]

Locations

1 United States site

Age

12 to 21 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Other

Compensation

Unknown

About the study

The primary objective of this study is to better understand factors contributing to
variations in hydroxyurea (HU) adherence behavior in adolescents and young adults (AYA) with
sickle cell disease (SCD). To meet this objective, the researchers will conduct a prospective
cohort study to determine the longitudinal relationship between HU adherence and
health-related quality of life (HRQOL) overtime among AYA with SCD. The long-term goal of
this research is to promote medication adherence behavior and improve health outcomes in AYA
with SCD.

participation requirements

– Age 12-21 years old

– Any sickle cell disease genotype

– On steady state of hydroxyurea for 2 months

– Own or have access to a smartphone

– Parents of patients that meet the eligibility criteria and are enrolled in the study
will be included

participation restrictions

– Patients with recent hospitalizations within the past 7 days

Locations

  • Chicago, Illinois, United States, Ann & Robert H Lurie Children's Hospital of Chicago, 60611 [Recruiting]

More info

View on ClinicalTrials.gov
Enroll Now